findmyKOL
Clinical trialNCT01326598CompletedObservational

Effectiveness of V-Go™ for Patients With Diabetes in a Real-world Setting

SponsorValeritas, Inc.Enrollment270Type 2 Diabetes Mellitus
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aim of the present study is to observe glycemic control, dose requirements, hypoglycemia risk, other possible adverse effects and weight changes, as well as to compare these parameters to prior treatment when patients with type 2 diabetes are initiated and treated using V-Go during circumstances as close to normal clinical practice as possible.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • San Diego Coastal Endocrinology Group

    Chula Vista, California, United States

  • Nancy J. Bohannon Med. Corp

    San Francisco, California, United States

  • Western Connecticut Health Network, Inc.

    Danbury, Connecticut, United States

  • Medsol Clinical Research Center

    Port Charlotte, Florida, United States

  • Atlanta Diabetes Associates

    Atlanta, Georgia, United States

  • Albert Johary M.D., P.C.

    Dunwoody, Georgia, United States

  • Endocrine Research Solutions, Inc.

    Roswell, Georgia, United States

  • Midamerica Diabetes Associates

    Wichita, Kansas, United States

  • Model Clinical Research

    Baltimore, Maryland, United States

  • Grunberger Diabetes Institute

    Bloomfield Hills, Michigan, United States

  • North Jersey Endocrine Consultants, Llcand

    Denville, New Jersey, United States

  • Parsippany Endocrine, Llc

    Parsippany, New Jersey, United States

  • Regional Endocrinology Associates, Pc

    Santa Fe, New Mexico, United States

  • North Shore Diabetes & Endocrine Assoc.

    New Hyde Park, New York, United States

  • Endocrine Associates of Long Island, Pc

    Smithtown, New York, United States

  • Middle Country Endocrinology, P.C.

    Smithtown, New York, United States

  • University Physicians Group

    Staten Island, New York, United States

  • Physicians East, Pa

    Greenville, North Carolina, United States

  • Diabetes & Endocrinology Consultants

    Morehead City, North Carolina, United States

  • Down East Medical Associates

    Morehead City, North Carolina, United States

  • Pmg Research of Winston-Salem

    Winston-Salem, North Carolina, United States

  • Alan B. Schorr, Do Face

    Langhorne, Pennsylvania, United States

  • Pmg Research of Bristol

    Bristol, Tennessee, United States

  • University Diabetes & Endocrine Consultants

    Chattanooga, Tennessee, United States

  • Pmg Research of Knoxville

    Knoxville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2012
Primary completion
31 Mar 2014
Completion
31 May 2014
Last update posted
2 Jun 2015
Registered enrollment
270
Registry id
NCT01326598

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.